Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: TN ER-/PR-/HER2- Breast Cancer|Triple Negative Breast Cancer|HER2-positive Breast Cancer|ERany/PRany/HER2+ Breast Cancer
Interventions: RADIATION: Standard Trimodality Breast Imaging
Sponsor: Masonic Cancer Center, University of Minnesota